APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-HBV Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti-HBV Drugs Industry Growth and Trends Forecast to 2032

29 December 202592 pages

Choose your research edition.

Industry ResearchAnti-HBV Drugs Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-HBV Drugs Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Anti-HBV Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-HBV Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-HBV Drugs Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Anti-HBV Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti-HBV Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti-HBV Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-HBV Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-HBV Drugs include Bristol-Myers Squibb, Genova, Gilead Sciences, Hansoh Pharmaceutical, Sinovac Biotech, GlaxoSmithKline, Roche, Merck and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti-HBV Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-HBV Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-HBV Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-HBV Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti-HBV Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-HBV Drugs Market by Company

Bristol-Myers Squibb

Genova

Gilead Sciences

Hansoh Pharmaceutical

Sinovac Biotech

GlaxoSmithKline

Roche

Merck

Novartis

Anti-HBV Drugs Segment by Type

Nucleotide Analogues (NA)

Interferon (IFN)

Others

Anti-HBV Drugs Segment by Application

Minor

Adult

Anti-HBV Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-HBV Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-HBV Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-HBV Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-HBV Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti-HBV Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Nucleotide Analogues (NA) Table 2. Major Company of Interferon (IFN) Table 3. Major Company of Others Table 4. Global Anti-HBV Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Anti-HBV Drugs Sales by Type (2021-2026) & (K Units) Table 6. Global Anti-HBV Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Anti-HBV Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Anti-HBV Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Anti-HBV Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Anti-HBV Drugs Sales by Type (2027-2032) & (K Units) Table 11. Global Anti-HBV Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Anti-HBV Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Anti-HBV Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Anti-HBV Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Anti-HBV Drugs Sales by Type (2021-2026) & (K Units) Table 16. North America Anti-HBV Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Anti-HBV Drugs Sales by Type (2021-2026) & (K Units) Table 18. Europe Anti-HBV Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Anti-HBV Drugs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Anti-HBV Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Anti-HBV Drugs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Anti-HBV Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Anti-HBV Drugs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Anti-HBV Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Anti-HBV Drugs Industry Trends Table 26. Anti-HBV Drugs Industry Drivers Table 27. Anti-HBV Drugs Industry Opportunities and Challenges Table 28. Anti-HBV Drugs Industry Restraints Table 29. Global Anti-HBV Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Anti-HBV Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Anti-HBV Drugs Sales by Company (2021-2026) & (K Units) Table 32. Global Anti-HBV Drugs Sales Share by Company (2021-2026) Table 33. Global Anti-HBV Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Anti-HBV Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Anti-HBV Drugs Major Company Production Sites and Headquarters Table 36. Global Anti-HBV Drugs Company, Product Type & Application Table 37. Global Anti-HBV Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Anti-HBV Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Anti-HBV Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Anti-HBV Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Anti-HBV Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Anti-HBV Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Anti-HBV Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Anti-HBV Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Anti-HBV Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Anti-HBV Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Anti-HBV Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Anti-HBV Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Anti-HBV Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Anti-HBV Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Anti-HBV Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Anti-HBV Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Anti-HBV Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Anti-HBV Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Anti-HBV Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Anti-HBV Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Anti-HBV Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Anti-HBV Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Anti-HBV Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Anti-HBV Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Anti-HBV Drugs Sales by Application (2021-2026) & (K Units) Table 63. North America Anti-HBV Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Anti-HBV Drugs Sales by Application (2021-2026) & (K Units) Table 65. Europe Anti-HBV Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Anti-HBV Drugs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Anti-HBV Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Anti-HBV Drugs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Anti-HBV Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Anti-HBV Drugs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Anti-HBV Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Bristol-Myers Squibb Company Information Table 73. Bristol-Myers Squibb Business Overview Table 74. Bristol-Myers Squibb Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Bristol-Myers Squibb Anti-HBV Drugs Product Portfolio Table 76. Bristol-Myers Squibb Recent Development Table 77. Genova Company Information Table 78. Genova Business Overview Table 79. Genova Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Genova Anti-HBV Drugs Product Portfolio Table 81. Genova Recent Development Table 82. Gilead Sciences Company Information Table 83. Gilead Sciences Business Overview Table 84. Gilead Sciences Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Gilead Sciences Anti-HBV Drugs Product Portfolio Table 86. Gilead Sciences Recent Development Table 87. Hansoh Pharmaceutical Company Information Table 88. Hansoh Pharmaceutical Business Overview Table 89. Hansoh Pharmaceutical Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Hansoh Pharmaceutical Anti-HBV Drugs Product Portfolio Table 91. Hansoh Pharmaceutical Recent Development Table 92. Sinovac Biotech Company Information Table 93. Sinovac Biotech Business Overview Table 94. Sinovac Biotech Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sinovac Biotech Anti-HBV Drugs Product Portfolio Table 96. Sinovac Biotech Recent Development Table 97. GlaxoSmithKline Company Information Table 98. GlaxoSmithKline Business Overview Table 99. GlaxoSmithKline Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. GlaxoSmithKline Anti-HBV Drugs Product Portfolio Table 101. GlaxoSmithKline Recent Development Table 102. Roche Company Information Table 103. Roche Business Overview Table 104. Roche Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Roche Anti-HBV Drugs Product Portfolio Table 106. Roche Recent Development Table 107. Merck Company Information Table 108. Merck Business Overview Table 109. Merck Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Merck Anti-HBV Drugs Product Portfolio Table 111. Merck Recent Development Table 112. Novartis Company Information Table 113. Novartis Business Overview Table 114. Novartis Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Novartis Anti-HBV Drugs Product Portfolio Table 116. Novartis Recent Development Table 117. North America Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. North America Anti-HBV Drugs Sales by Country (2021-2026) & (K Units) Table 119. North America Anti-HBV Drugs Sales Market Share by Country (2021-2026) Table 120. North America Anti-HBV Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 121. North America Anti-HBV Drugs Sales Market Share Forecast by Country (2027-2032) Table 122. North America Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America Anti-HBV Drugs Market Size by Country (2021-2026) & (US$ Million) Table 124. North America Anti-HBV Drugs Market Share by Country (2021-2026) Table 125. North America Anti-HBV Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America Anti-HBV Drugs Market Share Forecast by Country (2027-2032) Table 127. Europe Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Europe Anti-HBV Drugs Sales by Country (2021-2026) & (K Units) Table 129. Europe Anti-HBV Drugs Sales Market Share by Country (2021-2026) Table 130. Europe Anti-HBV Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 131. Europe Anti-HBV Drugs Sales Market Share Forecast by Country (2027-2032) Table 132. Europe Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe Anti-HBV Drugs Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe Anti-HBV Drugs Market Share by Country (2021-2026) Table 135. Europe Anti-HBV Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe Anti-HBV Drugs Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Anti-HBV Drugs Sales by Country (2021-2026) & (K Units) Table 139. Asia-Pacific Anti-HBV Drugs Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific Anti-HBV Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 141. Asia-Pacific Anti-HBV Drugs Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Anti-HBV Drugs Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific Anti-HBV Drugs Market Share by Country (2021-2026) Table 145. Asia-Pacific Anti-HBV Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific Anti-HBV Drugs Market Share Forecast by Country (2027-2032) Table 147. Latin America Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Latin America Anti-HBV Drugs Sales by Country (2021-2026) & (K Units) Table 149. Latin America Anti-HBV Drugs Sales Market Share by Country (2021-2026) Table 150. Latin America Anti-HBV Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 151. Latin America Anti-HBV Drugs Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America Anti-HBV Drugs Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America Anti-HBV Drugs Market Share by Country (2021-2026) Table 155. Latin America Anti-HBV Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America Anti-HBV Drugs Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Anti-HBV Drugs Sales by Country (2021-2026) & (K Units) Table 159. Middle East and Africa Anti-HBV Drugs Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa Anti-HBV Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 161. Middle East and Africa Anti-HBV Drugs Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Anti-HBV Drugs Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa Anti-HBV Drugs Market Share by Country (2021-2026) Table 165. Middle East and Africa Anti-HBV Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa Anti-HBV Drugs Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Anti-HBV Drugs Distributors List Table 170. Anti-HBV Drugs Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Anti-HBV Drugs Image Figure 2. Global Anti-HBV Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-HBV Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-HBV Drugs Sales (2021-2032) & (K Units) Figure 5. Nucleotide Analogues (NA) Image Figure 6. Global Nucleotide Analogues (NA) Sales YoY Growth (2021-2032) & (K Units) Figure 7. Interferon (IFN) Image Figure 8. Global Interferon (IFN) Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Anti-HBV Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Anti-HBV Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Anti-HBV Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Anti-HBV Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Anti-HBV Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Anti-HBV Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Anti-HBV Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Anti-HBV Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Anti-HBV Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Anti-HBV Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Anti-HBV Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Anti-HBV Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Anti-HBV Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Minor Image Figure 26. Global Minor Sales YoY Growth (2021-2032) & (K Units) Figure 27. Adult Image Figure 28. Global Adult Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Anti-HBV Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Anti-HBV Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Anti-HBV Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Anti-HBV Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Anti-HBV Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Anti-HBV Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Anti-HBV Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Anti-HBV Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Anti-HBV Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Anti-HBV Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Anti-HBV Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Anti-HBV Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Anti-HBV Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Anti-HBV Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Anti-HBV Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Anti-HBV Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Anti-HBV Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Anti-HBV Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Anti-HBV Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Anti-HBV Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Anti-HBV Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Anti-HBV Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Anti-HBV Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Anti-HBV Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Anti-HBV Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Anti-HBV Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Anti-HBV Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Anti-HBV Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Anti-HBV Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Anti-HBV Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Anti-HBV Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Anti-HBV Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Anti-HBV Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Anti-HBV Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Nucleotide Analogues (NA)
  • Interferon (IFN)
  • Others
Applications
  • Minor
  • Adult
Companies covered
  • Bristol-Myers Squibb
  • Genova
  • Gilead Sciences
  • Hansoh Pharmaceutical
  • Sinovac Biotech
  • GlaxoSmithKline
  • Roche
  • Merck
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-HBV Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti-HBV Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti-HBV Drugs Market by Type
  6. 1.3.1 Nucleotide Analogues (NA)
  7. 1.3.2 Interferon (IFN)
  8. 1.3.3 Others
  9. 1.4 Global Anti-HBV Drugs Market Size by Type
  10. 1.4.1 Global Anti-HBV Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Anti-HBV Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Anti-HBV Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Anti-HBV Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Anti-HBV Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Anti-HBV Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Anti-HBV Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Anti-HBV Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti-HBV Drugs Industry Trends
  2. 2.2 Anti-HBV Drugs Industry Drivers
  3. 2.3 Anti-HBV Drugs Industry Opportunities and Challenges
  4. 2.4 Anti-HBV Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti-HBV Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti-HBV Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Anti-HBV Drugs Price (2021-2026)
  4. 3.4 Global Anti-HBV Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-HBV Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Anti-HBV Drugs Company, Product Type & Application
  7. 3.7 Global Anti-HBV Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-HBV Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-HBV Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-HBV Drugs Tier 1, Tier 2, and Tier 3
4 Anti-HBV Drugs Regional Status and Outlook
  1. 4.1 Global Anti-HBV Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti-HBV Drugs Historic Market Size by Region
  3. 4.2.1 Global Anti-HBV Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti-HBV Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti-HBV Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti-HBV Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Anti-HBV Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti-HBV Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti-HBV Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti-HBV Drugs by Application
  1. 5.1 Anti-HBV Drugs Market by Application
  2. 5.1.1 Minor
  3. 5.1.2 Adult
  4. 5.2 Global Anti-HBV Drugs Market Size by Application
  5. 5.2.1 Global Anti-HBV Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Anti-HBV Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Anti-HBV Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Anti-HBV Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Anti-HBV Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Anti-HBV Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Anti-HBV Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Anti-HBV Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bristol-Myers Squibb
  2. 6.1.1 Bristol-Myers Squibb Company Information
  3. 6.1.2 Bristol-Myers Squibb Business Overview
  4. 6.1.3 Bristol-Myers Squibb Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bristol-Myers Squibb Anti-HBV Drugs Product Portfolio
  6. 6.1.5 Bristol-Myers Squibb Recent Developments
  7. 6.2 Genova
  8. 6.2.1 Genova Company Information
  9. 6.2.2 Genova Business Overview
  10. 6.2.3 Genova Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Genova Anti-HBV Drugs Product Portfolio
  12. 6.2.5 Genova Recent Developments
  13. 6.3 Gilead Sciences
  14. 6.3.1 Gilead Sciences Company Information
  15. 6.3.2 Gilead Sciences Business Overview
  16. 6.3.3 Gilead Sciences Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Gilead Sciences Anti-HBV Drugs Product Portfolio
  18. 6.3.5 Gilead Sciences Recent Developments
  19. 6.4 Hansoh Pharmaceutical
  20. 6.4.1 Hansoh Pharmaceutical Company Information
  21. 6.4.2 Hansoh Pharmaceutical Business Overview
  22. 6.4.3 Hansoh Pharmaceutical Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hansoh Pharmaceutical Anti-HBV Drugs Product Portfolio
  24. 6.4.5 Hansoh Pharmaceutical Recent Developments
  25. 6.5 Sinovac Biotech
  26. 6.5.1 Sinovac Biotech Company Information
  27. 6.5.2 Sinovac Biotech Business Overview
  28. 6.5.3 Sinovac Biotech Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sinovac Biotech Anti-HBV Drugs Product Portfolio
  30. 6.5.5 Sinovac Biotech Recent Developments
  31. 6.6 GlaxoSmithKline
  32. 6.6.1 GlaxoSmithKline Company Information
  33. 6.6.2 GlaxoSmithKline Business Overview
  34. 6.6.3 GlaxoSmithKline Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GlaxoSmithKline Anti-HBV Drugs Product Portfolio
  36. 6.6.5 GlaxoSmithKline Recent Developments
  37. 6.7 Roche
  38. 6.7.1 Roche Company Information
  39. 6.7.2 Roche Business Overview
  40. 6.7.3 Roche Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Roche Anti-HBV Drugs Product Portfolio
  42. 6.7.5 Roche Recent Developments
  43. 6.8 Merck
  44. 6.8.1 Merck Company Information
  45. 6.8.2 Merck Business Overview
  46. 6.8.3 Merck Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Merck Anti-HBV Drugs Product Portfolio
  48. 6.8.5 Merck Recent Developments
  49. 6.9 Novartis
  50. 6.9.1 Novartis Company Information
  51. 6.9.2 Novartis Business Overview
  52. 6.9.3 Novartis Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Novartis Anti-HBV Drugs Product Portfolio
  54. 6.9.5 Novartis Recent Developments
7 North America by Country
  1. 7.1 North America Anti-HBV Drugs Sales by Country
  2. 7.1.1 North America Anti-HBV Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti-HBV Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Anti-HBV Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti-HBV Drugs Market Size by Country
  6. 7.2.1 North America Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti-HBV Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti-HBV Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti-HBV Drugs Sales by Country
  2. 8.1.1 Europe Anti-HBV Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti-HBV Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti-HBV Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti-HBV Drugs Market Size by Country
  6. 8.2.1 Europe Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti-HBV Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti-HBV Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti-HBV Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Anti-HBV Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti-HBV Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti-HBV Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti-HBV Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti-HBV Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti-HBV Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti-HBV Drugs Sales by Country
  2. 10.1.1 South America Anti-HBV Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti-HBV Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Anti-HBV Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti-HBV Drugs Market Size by Country
  6. 10.2.1 South America Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti-HBV Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti-HBV Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti-HBV Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Anti-HBV Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti-HBV Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti-HBV Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti-HBV Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti-HBV Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti-HBV Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti-HBV Drugs Value Chain Analysis
  2. 12.1.1 Anti-HBV Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti-HBV Drugs Production Mode & Process
  7. 12.2 Anti-HBV Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti-HBV Drugs Distributors
  10. 12.2.3 Anti-HBV Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst